<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2017-628-633</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-2466</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Факторы риска развития стеноза коронарных артерий у больных ревматоидным артритом</article-title><trans-title-group xml:lang="en"><trans-title>RISK FACTORS OF CORONARY ARTERY STENOSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Герасимова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gerasimova</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">gerasimovaev@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Попкова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Popkova</surname><given-names>T. V.</given-names></name></name-alternatives><email xlink:type="simple">gerasimovaev@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>D. S.</given-names></name></name-alternatives><email xlink:type="simple">gerasimovaev@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Круглый</surname><given-names>Л. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Kruglyi</surname><given-names>L. B.</given-names></name></name-alternatives><email xlink:type="simple">gerasimovaev@list.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фомичева</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fomicheva</surname><given-names>O. A.</given-names></name></name-alternatives><email xlink:type="simple">gerasimovaev@list.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карпов</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Karpov</surname><given-names>Yu. A.</given-names></name></name-alternatives><email xlink:type="simple">gerasimovaev@list.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Насонов</surname><given-names>Е. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Nasonov</surname><given-names>E. L.</given-names></name></name-alternatives><email xlink:type="simple">gerasimovaev@list.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Cardiology, Ministry of Health of Russia, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва;&#13;
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России, кафедра ревматологии Института профессионального образования, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology, Moscow;&#13;
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Department of Rheumatology, Institute of Professional Education, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>04</day><month>01</month><year>2018</year></pub-date><volume>55</volume><issue>6</issue><fpage>628</fpage><lpage>633</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Герасимова Е.В., Попкова Т.В., Новикова Д.С., Круглый Л.Б., Фомичева О.А., Карпов Ю.А., Насонов Е.Л., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Герасимова Е.В., Попкова Т.В., Новикова Д.С., Круглый Л.Б., Фомичева О.А., Карпов Ю.А., Насонов Е.Л.</copyright-holder><copyright-holder xml:lang="en">Gerasimova E.V., Popkova T.V., Novikova D.S., Kruglyi L.B., Fomicheva O.A., Karpov Y.A., Nasonov E.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/2466">https://rsp.mediar-press.net/rsp/article/view/2466</self-uri><abstract><p>Цель исследования – определить частоту и степень атеросклеротического поражения коронарных артерий по данным коронароангиографии у больных ревматоидным артритом (РА) с подозрением на ишемическую болезнь сердца (ИБС), оценить связь его развития с традиционными факторами риска (ФР), маркерами воспаления и терапией РА. Материал и методы. В исследование включено 25 мужчин и 38 женщин с диагнозом РА и подозрением на ИБС или с верифицированной ИБС, медиана возраста – 58 [52; 63] лет, длительности РА – 10,5 [7; 23] года. 85% больных были серопозитивны по IgM ревматоидному фактору (РФ), 69% – по антителам к циклическому цитруллинированному пептиду (АЦЦП). Медиана DAS28 – 4,7 [3,3; 5,8]. Стеноз коронарных артерий диагностировали при наличии гемодинамически значимого сужения их просвета (≥50%). Результаты и обсуждение. Стеноз коронарных артерий диагностирован у 22 (35%) больных (I группа), из них у 15 (68%) поражение было однососудистым, у 7 (32%) – трехсосудистым; двухсосудистого поражения не было ни у одного пациента с РА. У 41 (65%) больного изменений коронарных артерий не обнаружено (II группа). У мужчин частота стеноза коронарных артерий (15 из 25; 60%) оказалась выше, чем у женщин (7 из 38; 18%; р&lt;0,05). В I группе ИБС встречалась чаще, чем во II: инфаркт миокарда (ИМ) в анамнезе на- блюдался у 32 и 2%, стенокардия напряжения с типичным болевым синдромом – у 77 и 32% больных соот- ветственно (p&gt;&lt;0,05). Традиционные ФР в обеих группах встречались с одинаковой частотой. В I группе об- наружена более низкая концентрация холестерина (ХС) липопротеидов высокой плотности (ЛПВП), чем во II (медиана – 1,2 [1,0; 1,5] ммоль/л и 1,3 [1,2; 1,8] ммоль/л соответственно; р=0,025). Атеросклеротические бляшки внутренней сонной артерии (ВСА) обнаружены у 19 и 16%, увеличение толщины интимы ВСА – у 53 и 57% больных I и II групп соответственно (р&gt;0,05). Проведенный множественный регрессионный анализ не выявил связи развития стеноза коронарных артерий с возрастом, полом, значением DAS28, СОЭ, уровнем С-реактивного белка, концентрацией ХС, ХС липопротеидов низкой плотности (ЛПНП), ХС ЛПВП, применением противоревматических препаратов. Изучавшиеся показатели не позволили прогнозировать развитие стеноза коронарных артерий, хотя различия по возрасту приближались к уровню статистической достоверности: отношение шансов (ОШ) – 0,85 (95% ДИ 0,72–1,0); р=0,05. Остальные параметры, включая уровень ХС ЛПВП&lt; 1,2 для женщин и &lt; 1,0 ммоль/л для мужчин (ОШ = 0,82; 95% ДИ 0,64–0,90; р=0,09), имели меньший вес. Выводы. У каждого третьего больного РА с подозрением на ИБС или с верифицированной ИБС диагностируется стеноз коронарных артерий. Мужской пол и низкий уровень ХС ЛПВП могут способствовать повышению риска развития стеноза коронарных артерий.</p><p> </p></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to determine frequency and grade of the coronary artery (CA) damage using coronary angiography data in patients with rheumatoid arthritis (RA) and suspected coronary artery disease (CAD); to evaluate the association of its progress with traditional risk factors (TRF), inflammatory markers and antirheumatic therapy. Subjects and methods. 25 male and 38 female RA patients with suspected or verified CAD, (median age was 58 [52; 63] years, RA duration – 10,5 [7; 23] years), were included in the study. 85% of patients were seropositive for IgM rheumatoid factor, 69% – for cyclic citrullinated peptide (CCP) antibodies. DAS28 median was 4,7 [3,3; 5,8]. CA stenosis was diagnosed if hemodynamically significant narrowing of the artery lumen (≥50%) was present. Results and discussion. CA stenosis was diagnosed in 22 (35%) patients (group I), 15 (68%) of them had single vessel damage, 7 (32%) – three-vessel involvement; the damage of two vessels was not diagnosed in any RA case. 41 (65%) patients had no lesions in CA (group II). The frequency of CA stenosis was higher in male patients (15 out of 25; 60%) than in female (7 out of 38; 18%; p&lt;0,05). CAD incidence in group I was higher than in group II: myocardial infarction (MI) history was documented in 32% and 2%, stable angina pectoris in 77% and 32% of cases respectively, p&gt;&lt;0,05. TRF incidence was similar in both groups. Concentration of serum high density lipoprotein cholesterol (HDLC) in group I was lower than in group II (median 1,2 [1,0; 1,5] vs 1,3 [1,2;1,8] mmol/L respectively, p=0,025). Carotid artery atherosclerotic plaques were detected in 19% and 16%, carotid artery intimamedia thickening – in 53% and 57% of patients respectively (p&gt;0,05). The multiple regression analysis did not revealed any direct relationship of CA stenosis development with age, gender, DAS28, erythrocyte sedimentation rate, C-reactive protein level, concentration of cholesterol, low density lipoprotein cholesterol, HDLC, and consumption of anti-rheumatic drugs. The prediction of CA stenosis development was not possible with parameters used in this study. However, differences in age were the closest to statistical significance (OR=0,85; 95% CI [0,72–1,0], p=0,05). Other parameters, including HDLC level&lt; 1,2 mmol/L for women and&lt; 1,0 for men (OR 0,82; 95% CI [0,64–0,90], p=0,09) had less predictive power. Conclusion: CA stenosis was diagnosed in every third patient with RA and suspected CAD or verified CAD. Male gender and low level of HDLC may increase the risk of CA stenosis.</p></sec><sec><title> </title><p> </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ревматоидный артрит</kwd><kwd>стеноз коронарных артерий</kwd><kwd>традиционные факторы риска</kwd><kwd>атеросклеротическое поражение сосудов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>rheumatoid arthritis</kwd><kwd>coronary artery stenosis</kwd><kwd>traditional risk factors</kwd><kwd>atherosclerotic vascular lesions</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов ЕЛ, Каратеев ДЕ, Балабанова РМ. Ревматоидный артрит. В кн.: Насонов ЕЛ, Насонова ВА, редакторы. Ревматология. Национальное руководство. Москва: ГЭОТАР-Медиа; 2008. С. 290-331. [Nasonov EL, Karateev DE, Balabanova RM. Rheumatoid arthritis. In: Nasonov EL, Nasonova VA, editors. Revmatologiya. Natsional'noe rukovodstvo [Rheumatology. National Guide]. Moscow: GEOTAR-media; 2008. P. 290-331].</mixed-citation><mixed-citation xml:lang="en">Насонов ЕЛ, Каратеев ДЕ, Балабанова РМ. Ревматоидный артрит. В кн.: Насонов ЕЛ, Насонова ВА, редакторы. Ревматология. Национальное руководство. Москва: ГЭОТАР-Медиа; 2008. С. 290-331. [Nasonov EL, Karateev DE, Balabanova RM. Rheumatoid arthritis. In: Nasonov EL, Nasonova VA, editors. Revmatologiya. Natsional'noe rukovodstvo [Rheumatology. National Guide]. Moscow: GEOTAR-media; 2008. P. 290-331].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Yazdanyar A, Wasko MC, Kraemer KL, Ward MM. Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus. Arthritis Rheum. 2012 Aug;64(8):2429-37. doi: 10.1002/art.34428</mixed-citation><mixed-citation xml:lang="en">Yazdanyar A, Wasko MC, Kraemer KL, Ward MM. Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus. Arthritis Rheum. 2012 Aug;64(8):2429-37. doi: 10.1002/art.34428</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ranganath VK, Maranian P, Elashoff DA, et al. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis. Rheumatology (Oxford). 2013 Oct;52(10):1809-17. doi: 10.1093/rheumatology/ket224. Epub 2013 Jun 27.</mixed-citation><mixed-citation xml:lang="en">Ranganath VK, Maranian P, Elashoff DA, et al. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis. Rheumatology (Oxford). 2013 Oct;52(10):1809-17. doi: 10.1093/rheumatology/ket224. Epub 2013 Jun 27.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Semb AG, Kvien TK, Aastveit AH. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis. 2010;69:1996-2001. doi: 10.1136/ard.2009.126128</mixed-citation><mixed-citation xml:lang="en">Semb AG, Kvien TK, Aastveit AH. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis. 2010;69:1996-2001. doi: 10.1136/ard.2009.126128</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Boyer JF, Gourraud PA, Cantagrel A, et al. Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine. 2011;78:179-83. doi: 10.1016/j.jbspin.2010.07.016</mixed-citation><mixed-citation xml:lang="en">Boyer JF, Gourraud PA, Cantagrel A, et al. Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine. 2011;78:179-83. doi: 10.1016/j.jbspin.2010.07.016</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012 Sep;71(9):1524-9. doi: 10.1136/annrheumdis-2011-200726</mixed-citation><mixed-citation xml:lang="en">Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012 Sep;71(9):1524-9. doi: 10.1136/annrheumdis-2011-200726</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005 Feb;52(2):402-11. doi: 10.1002/art.20853</mixed-citation><mixed-citation xml:lang="en">Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005 Feb;52(2):402-11. doi: 10.1002/art.20853</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Koivuniemi R, Paimela L, Suomalainen R, Leirisalo-Repo M. Cardiovascular diseases in patients with rheumatoid arthritis. Scand J Rheumatol. 2013;42(2):131-5.</mixed-citation><mixed-citation xml:lang="en">Koivuniemi R, Paimela L, Suomalainen R, Leirisalo-Repo M. Cardiovascular diseases in patients with rheumatoid arthritis. Scand J Rheumatol. 2013;42(2):131-5.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">doi: 10.3109/03009742.2012.723747. Epub 2012 Dec 18.</mixed-citation><mixed-citation xml:lang="en">doi: 10.3109/03009742.2012.723747. Epub 2012 Dec 18.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Holmqvist ME, Wedren S, Jacobsson LT, et al. Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med. 2010 Dec;268(6):578-85. doi: 10.1111/j.1365-2796.2010.02260.x</mixed-citation><mixed-citation xml:lang="en">Holmqvist ME, Wedren S, Jacobsson LT, et al. Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med. 2010 Dec;268(6):578-85. doi: 10.1111/j.1365-2796.2010.02260.x</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Rollefstad S, Ikdahl E, Hisdal J, et al. Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint Diseases. Front Med (Lausanne). 2015 Nov 10;2:80. doi: 10.3389/fmed.2015.00080. eCollection 2015.</mixed-citation><mixed-citation xml:lang="en">Rollefstad S, Ikdahl E, Hisdal J, et al. Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint Diseases. Front Med (Lausanne). 2015 Nov 10;2:80. doi: 10.3389/fmed.2015.00080. eCollection 2015.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Aubry MC, Maradit-Kremers H, Reinalda MS, et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol. 2007 May;34(5):937-42. Epub 2007 Mar 15.</mixed-citation><mixed-citation xml:lang="en">Aubry MC, Maradit-Kremers H, Reinalda MS, et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol. 2007 May;34(5):937-42. Epub 2007 Mar 15.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Karpouzas GA, Malpeso J, Choi TY, et al. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis. 2014 Oct;73(10):1797-804.</mixed-citation><mixed-citation xml:lang="en">Karpouzas GA, Malpeso J, Choi TY, et al. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis. 2014 Oct;73(10):1797-804.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">doi: 10.1136/annrheumdis-2013-203617. Epub 2013 Jul 25.</mixed-citation><mixed-citation xml:lang="en">doi: 10.1136/annrheumdis-2013-203617. Epub 2013 Jul 25.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015 Feb 21;36(8):482-9c. doi: 10.1093/eurheartj/ehu403. Epub 2014 Nov 27.</mixed-citation><mixed-citation xml:lang="en">Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015 Feb 21;36(8):482-9c. doi: 10.1093/eurheartj/ehu403. Epub 2014 Nov 27.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ostrom MP, Gopal A, Ahmadi N, et al. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol. 2008 Oct 14;52(16):1335-43. doi: 10.1016/j.jacc.2008.07.027</mixed-citation><mixed-citation xml:lang="en">Ostrom MP, Gopal A, Ahmadi N, et al. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol. 2008 Oct 14;52(16):1335-43. doi: 10.1016/j.jacc.2008.07.027</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Min JK, Dunning A, Lin FY, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011 Aug 16;58(8):849-60. doi: 10.1016/j.jacc.2011.02.074</mixed-citation><mixed-citation xml:lang="en">Min JK, Dunning A, Lin FY, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011 Aug 16;58(8):849-60. doi: 10.1016/j.jacc.2011.02.074</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Emond M, Mock MB, Davis KB, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994 Dec;90(6):2645-57.</mixed-citation><mixed-citation xml:lang="en">Emond M, Mock MB, Davis KB, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994 Dec;90(6):2645-57.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">doi: 10.1161/01.CIR.90.6.2645</mixed-citation><mixed-citation xml:lang="en">doi: 10.1161/01.CIR.90.6.2645</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ni H, Coady S, Rosamond W, et al. Trends from 1987 to 2004 in sudden death due to coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Am Heart J. 2009;157:46-52. doi: 10.1016/j.ahj.2008.08.016</mixed-citation><mixed-citation xml:lang="en">Ni H, Coady S, Rosamond W, et al. Trends from 1987 to 2004 in sudden death due to coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Am Heart J. 2009;157:46-52. doi: 10.1016/j.ahj.2008.08.016</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sidney S, Rosamond WD, Howard VJ, Luepker RV. The «heart disease and stroke statistics – 2013 update» and the need for a national cardiovascular surveillance system. Circulation. 2013;127:21. doi: 10.1161/CIRCULATIONAHA.112.155911</mixed-citation><mixed-citation xml:lang="en">Sidney S, Rosamond WD, Howard VJ, Luepker RV. The «heart disease and stroke statistics – 2013 update» and the need for a national cardiovascular surveillance system. Circulation. 2013;127:21. doi: 10.1161/CIRCULATIONAHA.112.155911</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Go AS, Mozaffarian D, Roger VL, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics – 2014 update: a report from the American heart association. Circulation. 2014;129:e28-292. doi: 10.1161/01.cir.0000442015.53336.12</mixed-citation><mixed-citation xml:lang="en">Go AS, Mozaffarian D, Roger VL, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics – 2014 update: a report from the American heart association. Circulation. 2014;129:e28-292. doi: 10.1161/01.cir.0000442015.53336.12</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000 Jul 22;356(9226):279-84.</mixed-citation><mixed-citation xml:lang="en">Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000 Jul 22;356(9226):279-84.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">doi: 10.1016/S0140-6736(00)02502-2</mixed-citation><mixed-citation xml:lang="en">doi: 10.1016/S0140-6736(00)02502-2</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Chang CC, Chang ML, Huang CH, et al. Carotid intima-media thickness and plaque occurrence in predicting stable angiographic coronary artery disease. Сlin Interv Aging. 2013;8:1283-8.</mixed-citation><mixed-citation xml:lang="en">Chang CC, Chang ML, Huang CH, et al. Carotid intima-media thickness and plaque occurrence in predicting stable angiographic coronary artery disease. Сlin Interv Aging. 2013;8:1283-8.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">doi: 10.2147/CIA.S49166. Epub 2013 Sep 25.</mixed-citation><mixed-citation xml:lang="en">doi: 10.2147/CIA.S49166. Epub 2013 Sep 25.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Asztalos BF, Collins D, Cupples LA, et al. Value of high density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the veteran's affairs HDL Intervention trial. Aterioscler Throm Vasc Biol. 2005;25:2185-21. doi: 10.1161/01.ATV.0000183727.90611.4f</mixed-citation><mixed-citation xml:lang="en">Asztalos BF, Collins D, Cupples LA, et al. Value of high density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the veteran's affairs HDL Intervention trial. Aterioscler Throm Vasc Biol. 2005;25:2185-21. doi: 10.1161/01.ATV.0000183727.90611.4f</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Lamon-Fava S, Herrington DM, Reboussin DM, et al. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol. 2008;28:575-9. doi: 10.1161/ATVBAHA.107.157123</mixed-citation><mixed-citation xml:lang="en">Lamon-Fava S, Herrington DM, Reboussin DM, et al. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol. 2008;28:575-9. doi: 10.1161/ATVBAHA.107.157123</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Watanabe H, Soderlund S, Soro-Paavonen A, et al. Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness. Arterioscler Thromb Vasc Biol. 2006;26:897-902. doi: 10.1161/01.ATV.0000209577.04246.c0</mixed-citation><mixed-citation xml:lang="en">Watanabe H, Soderlund S, Soro-Paavonen A, et al. Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness. Arterioscler Thromb Vasc Biol. 2006;26:897-902. doi: 10.1161/01.ATV.0000209577.04246.c0</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Williams PT, Feldman DE. Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort. Atherosclerosis. 2011 Jan;214(1):196-202. doi: 10.1016/j.atherosclerosis.2010.10.024. Epub 2010 Oct 23.</mixed-citation><mixed-citation xml:lang="en">Williams PT, Feldman DE. Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort. Atherosclerosis. 2011 Jan;214(1):196-202. doi: 10.1016/j.atherosclerosis.2010.10.024. Epub 2010 Oct 23.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Superko HR, Pendyala L, Williams PT, et al. High-density lipoprotein subclasses and their relationship to cardiovascular disease. J Clin Lipidol. 2012 Nov-Dec;6(6):496-523.</mixed-citation><mixed-citation xml:lang="en">Superko HR, Pendyala L, Williams PT, et al. High-density lipoprotein subclasses and their relationship to cardiovascular disease. J Clin Lipidol. 2012 Nov-Dec;6(6):496-523.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">doi: 10.1016/j.jacl.2012.03.001. Epub 2012 Mar 23.</mixed-citation><mixed-citation xml:lang="en">doi: 10.1016/j.jacl.2012.03.001. Epub 2012 Mar 23.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Arts E, Fransen J, Lemmers H, et al. High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study. Arthritis Res Ther. 2012 May 14;14(3):R116. doi: 10.1186/ar3842</mixed-citation><mixed-citation xml:lang="en">Arts E, Fransen J, Lemmers H, et al. High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study. Arthritis Res Ther. 2012 May 14;14(3):R116. doi: 10.1186/ar3842</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Charles-Schoeman C, Watanabe J, Lee YY, et al. Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum. 2009 Oct;60(10):2870-9. doi: 10.1002/art.24802</mixed-citation><mixed-citation xml:lang="en">Charles-Schoeman C, Watanabe J, Lee YY, et al. Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum. 2009 Oct;60(10):2870-9. doi: 10.1002/art.24802</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Charles-Schoeman C, Lee YY, Grijalva V, et al. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis. 2012 Jul;71(7):1157-62. doi: 10.1136/annrheumdis-2011-200493. Epub 2012 Jan 20.</mixed-citation><mixed-citation xml:lang="en">Charles-Schoeman C, Lee YY, Grijalva V, et al. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis. 2012 Jul;71(7):1157-62. doi: 10.1136/annrheumdis-2011-200493. Epub 2012 Jan 20.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Удачкина ЕВ, Новикова ДС, Попкова ТВ и др. Динамика липидных параметров крови у больных ранним ревматоидным артритом на фоне противоревматической терапии, проводимой по принципу «Лечение до достижения цели» (по данным 18-месячного наблюдения) Научно-практическая ревматология. 2016;54(2):164-70 [Udachkina EV, Novikova DS, Popkova TV, et al. Time course of changes in blood lipid parameters in patients with early rheumatoid arthritis during Treat-To-Target antirheumatic therapy: According to 18-month follow-up findings. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016;54(2):164-70 (In Russ.)]. doi: 10.14412/1995-4484-2016-164-170</mixed-citation><mixed-citation xml:lang="en">Удачкина ЕВ, Новикова ДС, Попкова ТВ и др. Динамика липидных параметров крови у больных ранним ревматоидным артритом на фоне противоревматической терапии, проводимой по принципу «Лечение до достижения цели» (по данным 18-месячного наблюдения) Научно-практическая ревматология. 2016;54(2):164-70 [Udachkina EV, Novikova DS, Popkova TV, et al. Time course of changes in blood lipid parameters in patients with early rheumatoid arthritis during Treat-To-Target antirheumatic therapy: According to 18-month follow-up findings. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016;54(2):164-70 (In Russ.)]. doi: 10.14412/1995-4484-2016-164-170</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Van Lenten BJ, Hama SY, de Beer FC, et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 1995 Dec;96(6):2758-67.</mixed-citation><mixed-citation xml:lang="en">Van Lenten BJ, Hama SY, de Beer FC, et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 1995 Dec;96(6):2758-67.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">doi: 10.1172/JCI118345</mixed-citation><mixed-citation xml:lang="en">doi: 10.1172/JCI118345</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Van Lenten BJ, Wagner AC, Nayak DP, et al. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation. 2001 May 8;103(18):2283-8. doi: 10.1161/01.CIR.103.18.2283</mixed-citation><mixed-citation xml:lang="en">Van Lenten BJ, Wagner AC, Nayak DP, et al. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation. 2001 May 8;103(18):2283-8. doi: 10.1161/01.CIR.103.18.2283</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
